The estimated Net Worth of Rui Rong Yuan is at least $27.4 Millón dollars as of 8 February 2016. Rui Yuan owns over 130,000 units of BeiGene Ltd stock worth over $27,449,500 and over the last 9 years Rui sold BGNE stock worth over $0.
Rui has made over 2 trades of the BeiGene Ltd stock since 2016, according to the Form 4 filled with the SEC. Most recently Rui bought 130,000 units of BGNE stock worth $240,500 on 8 February 2016.
The largest trade Rui's ever made was buying 130,000 units of BeiGene Ltd stock on 8 February 2016 worth over $240,500. On average, Rui trades about 130,000 units every 0 days since 2016. As of 8 February 2016 Rui still owns at least 130,000 units of BeiGene Ltd stock.
You can see the complete history of Rui Yuan stock trades at the bottom of the page.
Rui's mailing address filed with the SEC is C/O MOURANT OZANNES CORPORATE SERVICES, 94 SOLARIS AVENUE, CAMANA BAY, E9, KY1-1108.
Over the last 9 years, insiders at BeiGene Ltd have traded over $1,899,158,980 worth of BeiGene Ltd stock and bought 23,241,738 units worth $1,040,248,444 . The most active insiders traders include Bros. Advisors Lp667, L.P.B..., Investment Management, Ltd.... y Bros. Advisors Lp Baker Bro.... On average, BeiGene Ltd executives and independent directors trade stock every 13 days with the average trade being worth of $33,382,815. The most recent stock trade was executed by Xiaobin Wu on 3 September 2024, trading 5,556 units of BGNE stock currently worth $1,053,695.
BeiGene is a biotechnology company that specializes in the development of drugs for cancer treatment. BeiGene has developed several pharmaceuticals, including tislelizumab, a checkpoint inhibitor, and zanubrutinib.
BeiGene Ltd executives and other stock owners filed with the SEC include: